| Wed, Nov 18, 2009 |
| |
LPATH, INC Financials EDGAR Online Financials (Wed, Nov 18)
|
| Thu, Nov 12, 2009 |
| |
LPATH, INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Thu, Nov 12)
|
| Fri, Oct 23, 2009 |
| |
Lpath to Present at the 2009 BIOCOM Investor Conference Marketwire (Fri, Oct 23)
|
| Tue, Oct 20, 2009 |
| |
Lpath Receives Grants From the National Institutes of Health and Publishes Key Paper in the Proceedings of the National Academy of Sciences Marketwire (Tue, Oct 20)
|
| Thu, Oct 8, 2009 |
| |
Lpath's iSONEP Is Well Tolerated at All Dose Levels in a Phase 1 Trial in Wet-AMD Patients Marketwire (Thu, Oct 8)
|
| Thu, Sep 24, 2009 |
| |
LPATH, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exh EDGAR Online (Thu, Sep 24)
|
| |
Lpath and Merck Serono Extend ASONEP(TM) Collaboration Marketwire (Thu, Sep 24)
|
| Mon, Aug 24, 2009 |
| |
LPATH, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Mon, Aug 24)
|
| |
Lpath Achieves Merck Serono Milestone Marketwire (Mon, Aug 24)
|
| Tue, Aug 18, 2009 |
| |
Lpath Completes Enrollment of Patients in iSONEP(TM) Phase 1 Clinical Trial Marketwire (Tue, Aug 18)
|
| Fri, Aug 14, 2009 |
| |
Lpath to Present at the Southern California Investor Conference Marketwire (Fri, Aug 14)
|
| Wed, Aug 12, 2009 |
| |
LPATH, INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Wed, Aug 12)
|
| Tue, Jul 7, 2009 |
| |
LPATH, INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits EDGAR Online (Tue, Jul 7)
|
| Thu, Jul 2, 2009 |
| |
LPATH, INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant EDGAR Online (Thu, Jul 2)
|
| Fri, Jun 5, 2009 |
| |
LPATH, INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits EDGAR Online (Fri, Jun 5)
|
| Thu, Jun 4, 2009 |
| |
Lpath Receives $3 Million Grant From the National Cancer Institute Marketwire (Thu, Jun 4)
|
| Mon, Jun 1, 2009 |
| |
Lpath to Provide First Quarter 2009 Business Review and Clinical Update Conference Call on Thursday, June 4 at 4:30 p.m. ET Marketwire (Mon, Jun 1)
|
| Fri, May 15, 2009 |
| |
LPATH, INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Fri, May 15)
|
| Mon, Apr 20, 2009 |
| |
Lpath Scientists and Collaborators Present Favorable New Study Data of Leading Cancer Drug Candidate, ASONEP(TM) Marketwire (Mon, Apr 20)
|
| |
Lpath Presents Compelling New Preclinical Results of Its Anti-Cancer Drug Candidate, Lpathomab(TM), at the AACR 100th Annual Meeting Marketwire (Mon, Apr 20)
|
| Older Headlines |
|
|
|
|